GOLGA2P6

Across TCGA pan-cancer cohorts, GOLGA2P6 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated GOLGA2P6 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher GOLGA2P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GOLGA2P6 expression acts as an unfavorable survival marker.

KICH, STAD, and HNSC are the cancer types where GOLGA2P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.773	0.943	.004	63	view →
STAD	OS	Tertile	All	0.422	0.608	.015	45	view →
HNSC	OS	Tertile	IV	0.370	0.665	.009	36	view →
UVM	OS	Tertile	All	0.218	0.696	.014	36	view →
UCEC	DFS	Tertile	All	0.427	0.665	.001	36	view →
KIRC	DFS	Tertile	IV	0.271	0.533	.028	18	view →
LIHC	DFS	Tertile	III,IV	0.040	0.334	<.001	9	view →
THCA	DFS	Tertile	IV	0.189	0.839	.001	9	view →
OV	OS	Tertile	IV	0.532	0.787	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

GOLGA2P6–KICH (OS)

Open the KICH breakdown →